Severe Combined Immunodeficiency
What's New
Last Posted: Mar 18, 2021
- Newborn screening for severe combined immunodeficiency: clinical and cost-effectiveness approaches.
Boyarchuk Oksana et al. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 2021 49(289) 80-83 - Gene Therapy for Monogenic Inherited Disorders.
Kirschner Janbernd et al. Deutsches Arzteblatt international 2021 117(51-52) 878-885 - An appraisal of the Wilson & Jungner criteria in the context of genomic-based newborn screening for inborn errors of immunity.
King Jovanka R et al. The Journal of allergy and clinical immunology 2021 Feb 147(2) 428-438 - A Decade Experience on Severe Combined Immunodeficiency Phenotype in Oman, Bridging to Newborn Screening.
Al Sukaiti Nashat et al. Frontiers in immunology 2020 11623199 - Newborn Screening for Severe Combined Immunodeficiency: 10-Year Experience at a Single Referral Center (2009-2018).
Thorsen Julia et al. Journal of clinical immunology 2021 Jan - [50 years of the Neonatal Screening Program in Catalonia.]
Marín Soria Jose Luis et al. Revista espanola de salud publica 2020 Dec 94 - [First universal newborn screening program for severe combined immunodeficiency in Europe. Three-years' experience in Catalonia.]
Argudo Ramírez Ana et al. Revista espanola de salud publica 2020 Dec 94 - Immune Reconstitution After Gene Therapy Approaches in Patients With X-Linked Severe Combined Immunodeficiency Disease.
Blanco Elena et al. Frontiers in immunology 2020 11608653 - Follow-Up for an Abnormal Newborn Screen for Severe Combined Immunodeficiencies (NBS SCID): A Clinical Immunology Society (CIS) Survey of Current Practices.
Knight Vijaya et al. International journal of neonatal screening 2020 Jun 6(3) - The Landscape of Severe Combined Immunodeficiency Newborn Screening in the United States in 2020: A Review of Screening Methodologies and Targets, Communication Pathways, and Long-Term Follow-Up Practices.
Sheller Ruthanne et al. Frontiers in immunology 2020 11577853
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
- CDC Information (3)
- NIH Information (8)
- COVID-19 (1)
- CDC Publications (2)
- Human Genome Epidemiologic Studies (9)
- Genomic Tests Evidence Synthesis (5)
- Genomic Tests Guidelines (2)
- Tier-Classified Guidelines (1)
- Pathogen Advanced Molecular Detection (5)
- State Public Health Genomics Programs (4)
- Reviews/Commentaries (48)
- Tools/Methods (1)
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Oct 1, 2020
- Page last updated:Apr 21, 2021
- Content source: